- Home
- IRON vs DCOM Comparison
IRON vs DCOM Comparison
Compare IRON & DCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- DCOM
- Stock Information
- Founded
- IRON 2017
- DCOM 1864
- Country
- IRON United States
- DCOM United States
- Employees
- IRON N/A
- DCOM N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- DCOM Major Banks
- Sector
- IRON Health Care
- DCOM Finance
- Exchange
- IRON Nasdaq
- DCOM Nasdaq
- Market Cap
- IRON 1.4B
- DCOM 1.2B
- IPO Year
- IRON N/A
- DCOM 1996
- Fundamental
- Price
- IRON $51.61
- DCOM $26.31
- Analyst Decision
- IRON Strong Buy
- DCOM Buy
- Analyst Count
- IRON 10
- DCOM 4
- Target Price
- IRON $93.40
- DCOM $33.88
- AVG Volume (30 Days)
- IRON 372.4K
- DCOM 201.6K
- Earning Date
- IRON 08-07-2025
- DCOM 07-22-2025
- Dividend Yield
- IRON N/A
- DCOM 3.79%
- EPS Growth
- IRON N/A
- DCOM N/A
- EPS
- IRON N/A
- DCOM 0.62
- Revenue
- IRON N/A
- DCOM $295,419,000.00
- Revenue This Year
- IRON N/A
- DCOM $46.03
- Revenue Next Year
- IRON N/A
- DCOM $16.60
- P/E Ratio
- IRON N/A
- DCOM $42.24
- Revenue Growth
- IRON N/A
- DCOM N/A
- 52 Week Low
- IRON $30.82
- DCOM $18.19
- 52 Week High
- IRON $68.73
- DCOM $37.60
- Technical
- Relative Strength Index (RSI)
- IRON 56.99
- DCOM 49.37
- Support Level
- IRON $48.87
- DCOM $25.69
- Resistance Level
- IRON $54.13
- DCOM $27.96
- Average True Range (ATR)
- IRON 2.31
- DCOM 0.61
- MACD
- IRON 0.07
- DCOM -0.03
- Stochastic Oscillator
- IRON 67.64
- DCOM 44.44
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.